Contact
Subscribe
e-Edition

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Facebook
Twitter
Instagram

26° Sunny
- Guymon, OK (73942)
  Today
  
  Sunny and windy. High 47F. Winds NNW at 25 to 35 mph. Winds could occasionally gust over 40 mph..
  
  Tonight
  
  Partly cloudy skies this evening will become overcast overnight. Low 23F. Winds NNW at 10 to 15 mph.
  
  Updated: January 16, 2026 @ 8:43 am
- Full Forecast

Site search

Home
News
- Local News
Sports
Entertainment
Obituaries
Photos
Videos
e-Edition
Classifieds
Archives
Best of 2025

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Aptevo Therapeutics Inc. - Common Stock (NQ:APVO)

9.134 +0.104 (+1.15%)

Streaming Delayed Price Updated: 10:22 AM EST, Jan 16, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Press Releases about Aptevo Therapeutics Inc. - Common Stock

< Previous 1 2 3 4 Next >

Aptevo Therapeutics Secures $60 Million Equity Line of Credit to Support Multispecific Portfolio Advancement, Increase Strategic Optionality

January 09, 2026

Via ACCESS Newswire

Aptevo Therapeutics Announces 1-for-18 Reverse Stock Split

December 26, 2025

Via ACCESS Newswire

Aptevo Therapeutics Highlights Compelling Safety and Strong Remission Rates for Mipletamig in Frontline AML at ASH 2025

December 09, 2025

Via ACCESS Newswire

Aptevo Debuts First Trispecific Antibody Candidate, APVO451, with Preclinical Data Demonstrating Immune Activation in Hard-to-Treat Solid Tumors

November 10, 2025

Via ACCESS Newswire

Aptevo Therapeutics Reports 3Q25 Financial Results And Provides A Business Update

November 06, 2025

Via ACCESS Newswire

Aptevo Therapeutics Interview to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

February 15, 2025

Via ACCESS Newswire

Aptevo Presenting Scientific and Clinical Updates at SITC and ASH, also Participating in Leading Financial and Industry Conferences in the Fourth Quarter

October 08, 2025

Via ACCESS Newswire

TOMI Environmental Solutions (NASDAQ: TOMZ): The Next Era of Disinfection Technology – More Stocks Inside

September 16, 2025

Via AB Newswire

Mipletamig Delivers 100% Remission Rate in Cohort 3 of RAINIER Trial for AML

September 16, 2025

Via ACCESS Newswire

Foremost Clean Energy and Aptevo Therapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

September 05, 2025

Via ACCESS Newswire

Aptevo Unveils Two Next-Generation, Industry Leading Trispecifics, Expanding CD3 Oncology Pipeline to Five Molecules

September 04, 2025

Via ACCESS Newswire

Aptevo Highlights APVO442, a CD3-Directed Preclinical Candidate for Prostate Cancer

August 13, 2025

Via ACCESS Newswire

Aptevo Therapeutics Reports 2Q25 Financial Results And Provides A Business Update

August 11, 2025

Via ACCESS Newswire

Aptevo Therapeutics and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

August 08, 2025

Via ACCESS Newswire

Aptevo Therapeutics Announces Closing of $8 Million Offering Priced At-the-Market Under Nasdaq Rules

June 20, 2025

Via ACCESS Newswire

Aptevo Expands Differentiated CD3 Portfolio with APVO455, Advancing a Suite of Targeted T-cell Engagers

June 20, 2025

Via ACCESS Newswire

Aptevo Therapeutics Announces $8 Million Offering Priced At-the-Market Under Nasdaq Rules

June 18, 2025

Via ACCESS Newswire

Mipletamig Demonstrates Compelling Clinical Activity in Frontline AML

June 18, 2025

Via ACCESS Newswire

Aptevo Participating in the BIO International Convention

June 13, 2025

Via ACCESS Newswire

Aptevo Therapeutics Announces 1-for-20 Reverse Stock Split as part of Nasdaq Compliance Plan

May 22, 2025

Via ACCESS Newswire

Aptevo Therapeutics Reports 1Q25 Financial Results And Provides an Update on Mipletamig

May 14, 2025

Via ACCESS Newswire

Aptevo Therapeutics Provides Program Update for Bispecific APVO711, a PD-L1 X CD40 that Combines a Checkpoint Inhibitor and Immune Activation

May 08, 2025

Via ACCESS Newswire

Aptevo Therapeutics Announces the Closing of $2.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

April 22, 2025

Via ACCESS Newswire

Aptevo Therapeutics $2.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

April 21, 2025

Via ACCESS Newswire

Aptevo Therapeutics Announces the Closing of $2.1 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules

April 04, 2025

Via ACCESS Newswire

$2 Stocks to Watch: PNPN.V, TIVC, APVO, OSRH, PRSO Biotech Breakthroughs, MedTech Momentum Metallic Metals Power Play & Signal Innovation

April 03, 2025

Via AB Newswire

Topics Intellectual Property

Aptevo Therapeutics $2.1 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules

April 03, 2025

Via ACCESS Newswire

RAINIER Trial Data Update: Two Additional AML Patients Achieve Remission Within 30 Days of Treatment

March 20, 2025

Via ACCESS Newswire

Aptevo Highlights APVO603: A Novel Bispecific Antibody Targeting 4-1BB and OX40 for Enhanced Solid Tumor Immunotherapy

March 18, 2025

Via ACCESS Newswire

Aptevo to Participate in March Conferences

March 06, 2025

Via ACCESS Newswire

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
News
Entertainment
Local Events
Sports
Business
Obituaries
Photo Galleries
Videos
Online Features

Services

Subscription Services
Submission Forms
Classifieds
Place an Ad
Promote Your Event
Search
Weather

guymondailyherald.com
301 N. E. 4th Street
Guymon, OK 73942
Phone: 580-338-3355
Email: reporter@guymondailyherald.com

Facebook
Twitter
Instagram

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Guymon, OK (73942)

Today

Tonight

Aptevo Therapeutics Inc. - Common Stock (NQ:APVO)

Press Releases about Aptevo Therapeutics Inc. - Common Stock

Sections

Services

Follow Us